| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |